Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Primary Biliary Cirrhosis (PBC) Clinical Research Samples

Discovery Life Sciences provides the highest quality Primary Biliary Cirrhosis (PBC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Primary Biliary Cirrhosis (PBC) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 11 of 11 total samples
 (0)
Checkout
Advanced Data View:
Showing 11 of 11 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Test 2Test Data 2Detail 2Test 3Test Data 3Detail 3Product
Details
Price
Buy
Blood TypeCo-morbiditiesConsent Status DateCurrent MedicationsIs PregnantLaboratory ResultsRisk GroupEver developed JaundiceLiver BiopsyCirrhosis?Ascites?History of Renal Insufficiency?BilirubinInitial Date of Disease DiagnosisCirrhosisAll Known Test Results Performed in Previous Six months
BBS0000-CY900356654081419DDPrimary Biliary Cirrhosis (PBC)United StatesSerum1.001.00$150.0072 YFemaleNon-Hispanic<-70C14-Aug-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)UltrasoundIncreased echotexture of the liver is non-specific and may reflect fatty infiltration2012-03-28CTLiver is unremarkable in appearance20-Jun-09$150.00UnknownHypothyroidism, Osteopenia, Anemia, Monoclonal paraproteinemia, Asymptomatic gallstones, Rheumatoid arthritis2019-08-14Levothyroxine, Benicar, Castia, Aspirin, Ocuvite, Os-Cal, Hydroxychloroquine sulfate, Pilocarpine HCl, Ursodiol, MeloxicamFalseALT: 22 U/L | AST: 34 U/L | GGT: 74 U/L | Bilirubin (direct): 0.3 mg/dL | Bilirubin (total): 0.6 mg/dL | 1-Jul-2019 |NoneNoYes in 2002 | Minimal portal lobular hepatitis, no evidence of fibrosisNoNoNo
BBS0000-CY900356655100419DDPrimary Biliary Cirrhosis (PBC)United StatesSerum1.001.00$150.0069 YFemaleNon-Hispanic<-70C04-Oct-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)Ultrasound1.8 cm hepatic echogenic nodule, probable hemagioma2018-01-21MRINo concerning liver lesions, Cirrhosis or scaarring not seen26-Feb-19$150.00UnknownDiabetes mellitus, Hyperlipidemia2019-10-04Metformin, Glipizide, UrsodiolFalseALT: 25 U/L | AST: 25 U/L | Bilirubin (total): 0.2 mg/dL | 19-Jul-2019 | Cholesterol: 194 mg/dL | Triglycerides: 45 mg/dL | HDL: 103 mg/dL | LDL: 82 mg/dL | 4-May-2019Hyperlipidemia, DiabetesNoNoNoNoNo
BBS0000-CY900356656071619DDPrimary Biliary Cirrhosis (PBC)United StatesSerum1.002.00$150.0081 YFemaleNon-Hispanic<-70C16-Jul-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)$150.00UnknownHypertension, Arthritis, Thyroid disease, High cholesterol2019-07-16Enalapril, Lovastatin, Amlodipine besylate, Carvedilol, Levothyroxine, TrazodoneFalseALT: 37 U/L | AST: 38 U/L | Bilirubin (total): 0.9 mg/dL | 4-Feb-2019 |HyperlipidemiaNoNoNoNoNo
BBS0000-CY900400675010820DDPrimary Biliary Cirrhosis (PBC)United StatesSerum4.501.00$150.0071 YFemaleNon-Hispanic<-70C08-Jan-20Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)UltrasoundCoarsened hepatic echotexture correlate for chronic liver disease12-Nov-19CT ScanLiver without suspicious focal lesion20-Nov-18$150.00UnknownThyroid disease2020-01-08Levothyroxine sodium, UrsodiolFalseALT: 19 U/L AST: 28 U/L Bilirubin (total): 0.4 mg/dL 30-Dec-2019NoneNoNoNoNoNo
EDP0000-AI900385849030920DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma1.601.00$75.0056 YFemaleNon-Hispanic<-70C09-Mar-20DiagnosisPrimary Biliary Cirrhosis (PBC)Abbott Architect | Kinetic W/O Pyridoxal Phosphate9 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate11 U/LAST$75.00Unknown0.7
EDP0000-CY900085553061219DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma1.001.00$150.0072 YFemaleNon-Hispanic<-70C12-Jun-19Clinical DiagnosisPBCX-ray | UltrasoundNodular contour consistent with cirrhosis | Cirrhotic hepatic morphology without focal lesion5-July-2016 | 9-Aug-2018CTNo biliary ductal dilation. Similar mild atrophy of right hepatic lobe28-Nov-17$150.00UnknownHypertension, Thyroid disease, Atrial fibrillationAtorvastatin, Digoxin, Montelukast, Spironolactone, Levoxyl, Letrozole, Ursodiol, Fosamax, Metoprolol succinateNoYes | Chronic hepatitis compatible with PBC Stage 1 Fibrosis
27-Aug-02
27-Aug-02Yes | CT scan
15-Nov
EDP0000-CY900356654081419DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma1.008.00$150.0072 YFemaleNon-Hispanic<-70C14-Aug-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)UltrasoundIncreased echotexture of the liver is non-specific and may reflect fatty infiltration2012-03-28CTLiver is unremarkable in appearance20-Jun-09$150.00UnknownHypothyroidism, Osteopenia, Anemia, Monoclonal paraproteinemia, Asymptomatic gallstones, Rheumatoid arthritis2019-08-14Levothyroxine, Benicar, Castia, Aspirin, Ocuvite, Os-Cal, Hydroxychloroquine sulfate, Pilocarpine HCl, Ursodiol, MeloxicamFalseALT: 22 U/L | AST: 34 U/L | GGT: 74 U/L | Bilirubin (direct): 0.3 mg/dL | Bilirubin (total): 0.6 mg/dL | 1-Jul-2019 |NoneNoYes in 2002 | Minimal portal lobular hepatitis, no evidence of fibrosisNoNoNo
EDP0000-CY900356656071619DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma1.006.00$150.0081 YFemaleNon-Hispanic<-70C16-Jul-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)$150.00UnknownHypertension, Arthritis, Thyroid disease, High cholesterol2019-07-16Enalapril, Lovastatin, Amlodipine besylate, Carvedilol, Levothyroxine, TrazodoneFalseALT: 37 U/L | AST: 38 U/L | Bilirubin (total): 0.9 mg/dL | 4-Feb-2019 |HyperlipidemiaNoNoNoNoNo
EDP0000-CY900356658071119DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma4.002.00$150.0059 YFemaleNon-Hispanic<-70C11-Jul-19Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)UltrasoundHeterogeneous liver2018-05-18MRIMild to moderate Cirrhosis5-Jun-18$150.00UnknownNone2019-07-11UrsodiolFalseALT: 19 U/L | AST: 23 U/L | Bilirubin (total): 0.5 mg/dL | Triglycerides: 70 mg/dL | HDL: 73 mg/dL | LDL: 102 mg/dL | 12-Feb-2019NoneNoYes | PBC stage 2 Fibrosis 9-Jul-2018Yes | MRI
5-Jun-18
NoNo
EDP0000-CY900400675010820DDPrimary Biliary Cirrhosis (PBC)United StatesK2 EDTA Plasma5.002.00$150.0071 YFemaleNon-Hispanic<-70C08-Jan-20Clinical DiagnosisPrimary Biliary Cirrhosis (PBC)UltrasoundCoarsened hepatic echotexture correlate for chronic liver disease12-Nov-19CT ScanLiver without suspicious focal lesion20-Nov-18$150.00UnknownThyroid disease2020-01-08Levothyroxine sodium, UrsodiolFalseALT: 19 U/L AST: 28 U/L Bilirubin (total): 0.4 mg/dL 30-Dec-2019NoneNoNoNoNoNo
EDP0000-FD900043137031618DDPrimary Biliary Cirrhosis (PBC)K2 EDTA Plasma1.002.00$150.0056 YFemaleNon-Hispanic<-70C16-Mar-18Clinical DiagnosisPrimary Biliary CirrhosisUltrasoundNormal Liver7-Jul-17$150.00UnknownNoneUrsodialNoNo12-May-17NoALT: 28 U/L | AST: 23 U/L | GGT: 72 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 2-Feb-2018

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.